

ANET is the first automated exchange transfusion system designed and built locally to solve Africa's critical neonatal healthcare crisis.






Neonatal jaundice is a leading cause of hospital admission. In some Ghanaian facilities, up to 67% of neonates are affected, yet current manual treatments remain slow, risky, and prone to error.
Manual exchange transfusions vary widely in safety, with studies showing adverse event rates as high as 74%, including thrombocytopenia and dangerous heart rate fluctuations.
The manual push-pull method is exhausting and inconsistent. Clinical data links manual instability to higher risks of air embolism and fluctuating intracranial pressure.
The burden of Kernicterus (irreversible brain damage) is ~73 per 100,000 live births in Sub-Saharan Africa—over 7 times higher than in high-income countries.
Behind every statistic is a mother's hope and a baby's future. ANET is our commitment to ensuring that hope becomes reality.

Every newborn deserves the best chance at a healthy start, regardless of where they're born.

ANET empowers healthcare providers to give mothers the peace of mind they deserve.
Neonatal jaundice affects millions of African babies annually
ANET is changing the odds, one life at a time
Replacing manual variability with digital precision. ANET's closed-loop system ensures consistent flow rates and patient safety at every step.


Advanced technology built with clinical rigor and practical engineering
PID-based microcontroller algorithms for precise motor regulation.
Stepper motors with encoders for sub-milliliter accuracy.
Air detection, voltage monitoring, and mechanical failsafes.
Dual temperature monitoring for safe blood handling.
Remote monitoring and procedure logging capabilities.
Multiple safety layers ensure patient protection.
Developed by DIPPER Lab, ANET proves that cutting-edge biomedical engineering can be done locally. We are redefining innovation through context-appropriate solutions that save lives.
Successfully engineered the first neonatal exchange transfusion device for African context
Completed
Conducting rigorous clinical trials with leading African medical institutions
In Progress
Scaling adoption across African healthcare systems and training programs
Next Phase